人类白细胞抗原
T细胞
生物
免疫学
主要组织相容性复合体
细胞
细胞生物学
抗原
免疫系统
遗传学
作者
Pascal M. Winterhalter,Linda Warmuth,Philipp Hilgendorf,Julius M. Schütz,Sarah Dötsch,Torsten Tonn,Luka Čičin‐Šain,Dirk H. Busch,Kilian Schober
出处
期刊:Blood Advances
[Elsevier BV]
日期:2024-04-19
卷期号:8 (13): 3416-3426
被引量:7
标识
DOI:10.1182/bloodadvances.2023011496
摘要
Abstract Adoptive cellular therapies have shown enormous potential but are complicated by personalization. Because of HLA mismatch, rejection of transferred T cells frequently occurs, compromising the T-cell graft's functionality. This obstacle has led to the development of HLA knock-out (KO) T cells as universal donor cells. Whether such editing directly affects T-cell functionality remains poorly understood. In addition, HLA KO T cells are susceptible to missing self-recognition through natural killer (NK) cells and lack of canonical HLA class I expression may represent a safety hazard. Engineering of noncanonical HLA molecules could counteract NK-cell recognition, but further complicates the generation of cell products. Here, we show that HLA KO does not alter T-cell functionality in vitro and in vivo. Although HLA KO abrogates allogeneic T-cell responses, it elicits NK-cell recognition. To circumvent this problem, we demonstrate that selective editing of individual HLA class I molecules in primary human T cells is possible. Such HLA reduction not only inhibits T-cell alloreactivity and NK-cell recognition simultaneously, but also preserves the T-cell graft's canonical HLA class I expression. In the presence of allogeneic T cells and NK cells, T cells with remaining expression of a single, matched HLA class I allele show improved functionality in vivo in comparison with conventional allogeneic T cells. Since reduction to only a few, most frequent HLA haplotypes would already be compatible with large shares of patient populations, this approach significantly extends the toolbox to generate broadly applicable cellular products.
科研通智能强力驱动
Strongly Powered by AbleSci AI